Analysis of clinical characteristics of mesalazine-induced cardiotoxicity
Background: Mesalazine is the first-line inflammatory bowel disease (IBD) treatment. However, it can cause fatal cardiotoxicity. We aimed to analyze the clinical characteristics of mesalazine-induced cardiotoxicity and provide evidence for clinical diagnosis, treatment, and prevention.Methods: We co...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Jezik: | English |
| Izdano: |
Frontiers Media S.A.
2022-09-01
|
| Serija: | Frontiers in Pharmacology |
| Teme: | |
| Online dostop: | https://www.frontiersin.org/articles/10.3389/fphar.2022.970597/full |